Kenneth G. Saag

60.5k total citations · 11 hit papers
476 papers, 26.7k citations indexed

About

Kenneth G. Saag is a scholar working on Orthopedics and Sports Medicine, Rheumatology and Surgery. According to data from OpenAlex, Kenneth G. Saag has authored 476 papers receiving a total of 26.7k indexed citations (citations by other indexed papers that have themselves been cited), including 176 papers in Orthopedics and Sports Medicine, 143 papers in Rheumatology and 121 papers in Surgery. Recurrent topics in Kenneth G. Saag's work include Bone health and osteoporosis research (168 papers), Rheumatoid Arthritis Research and Therapies (91 papers) and Gout, Hyperuricemia, Uric Acid (88 papers). Kenneth G. Saag is often cited by papers focused on Bone health and osteoporosis research (168 papers), Rheumatoid Arthritis Research and Therapies (91 papers) and Gout, Hyperuricemia, Uric Acid (88 papers). Kenneth G. Saag collaborates with scholars based in United States, Canada and Netherlands. Kenneth G. Saag's co-authors include Jeffrey R. Curtis, Elizabeth Delzell, Ted R. Mikuls, Nicole C. Wright, Jeroan J. Allison, Bess Dawson‐Hughes, Nivedita M. Patkar, Lang Chen, James R. Cerhan and Ethel S. Siris and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Kenneth G. Saag

463 papers receiving 25.8k citations

Hit Papers

The Recent Prevalence of Osteoporosis and Low B... 2004 2026 2011 2018 2014 2017 2022 2007 2018 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The Recent Prevalence of Osteoporosis and Low Bone Mass in the United States Based on Bone Mineral Density at the Femoral Neck or Lumbar Spine
    2014 1.3k citations Nicole C. Wright, Kenneth G. Saag et al. Journal of Bone and Mineral Research profile →
  2. Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis
    2017 942 citations Kenneth G. Saag et al. New England Journal of Medicine profile →
  3. The clinician’s guide to prevention and treatment of osteoporosis
    2022 623 citations Kenneth G. Saag et al. Osteoporosis International profile →
  4. Teriparatide or Alendronate in Glucocorticoid-Induced Osteoporosis
    2007 611 citations Kenneth G. Saag et al. New England Journal of Medicine profile →
  5. Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout
    2018 578 citations William B. White, Kenneth G. Saag et al. New England Journal of Medicine profile →
  6. Vitamin D intake is inversely associated with rheumatoid arthritis: Results from the Iowa Women's Health Study
    2004 578 citations Linda Merlino, Jeffrey R. Curtis et al. profile →
  7. Rheumatoid arthritis disease activity measures: American College of Rheumatology recommendations for use in clinical practice
    2012 553 citations Kenneth G. Saag et al. profile →
  8. 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: Initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features
    2011 549 citations Kenneth G. Saag et al. profile →
  9. American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid‐induced osteoporosis
    2010 516 citations Jeffrey R. Curtis, Kenneth G. Saag et al. profile →
  10. The clinical diagnosis of osteoporosis: a position statement from the National Bone Health Alliance Working Group
    2014 438 citations John P. Bilezikian, Kenneth G. Saag et al. Osteoporosis International profile →
  11. Trends in Prevalence of Gout Among US Asian Adults, 2011-2018
    2023 60 citations Kenneth G. Saag, Hyon K. Choi et al. profile →

Peers

Kenneth G. Saag
Comparison fields: 5 of 197
  • Orthopedics and Sports Medicine 8.6k
  • Rheumatology 7.4k
  • Surgery 6.0k
  • Oncology 5.1k
  • Molecular Biology 4.9k
Replace Daniel H. Solomon with:
Daniel H. Solomon United States
Jeffrey R. Curtis United States
Claus Christiansen Denmark
Michael Doherty United Kingdom
Cynthia S. Crowson United States
Hang Lee United States
Sherine E. Gabriel United States
Matthew H. Liang United States
Hyon K. Choi United States
Tore K Kvien Norway
Daniel H. Solomon United States View profile →
Citations per field, relative to Kenneth G. Saag
Kenneth G. Saag · 1×
Citations per year, relative to Kenneth G. Saag
Kenneth G. Saag · 1×

Countries citing papers authored by Kenneth G. Saag

Since Specialization
Citations

This map shows the geographic impact of Kenneth G. Saag's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenneth G. Saag with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenneth G. Saag more than expected).

Fields of papers citing papers by Kenneth G. Saag

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenneth G. Saag. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenneth G. Saag. The network helps show where Kenneth G. Saag may publish in the future.

Co-authorship network of co-authors of Kenneth G. Saag

This figure shows the co-authorship network connecting the top 25 collaborators of Kenneth G. Saag. A scholar is included among the top collaborators of Kenneth G. Saag based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenneth G. Saag. Kenneth G. Saag is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1
Evaluation of the efficacy and safety of a novel xanthine oxidase inhibitor, tigulixostat, in gout patients with hyperuricemia: Design of the EURELIA 1 and EURELIA 2 studies
2025 ·Contemporary Clinical Trials ·Kenneth G. Saag, Nicola Dalbeth, (unknown), Chang‐Fu Kuo, George Nuki, Fernando Pérez-Ruiz, William B. White, Ali Hariri, (unknown), (unknown), Song Han, Hyon K. Choi
0
2
Socioeconomic vulnerability and osteoporosis treatment disparities during COVID-19 lockdown among U.S. medicare enrollees who initiated romosozumab
2025 ·Osteoporosis International ·Ye Liu, Tarun Arora, Jingyi Zhang, Bisakha Sen, Dávid Becker, Ruoyan Sun, Huifeng Yun, Kenneth G. Saag, Jeffrey R. Curtis
0
3
“Burnout” Coupled with Workforce Shortages Spells Trouble: Innovative Solutions Are Essential for More Satisfying Rheumatology Practice
2023 ·Arthritis & Rheumatology ·(unknown), Daniel F. Battafarano, (unknown), Kenneth G. Saag
1
4
Risk of fracture in women with glucocorticoid requiring diseases is independent from glucocorticoid use: An analysis on a nation-wide database
2023 ·Bone ·Giovanni Adami, Davide Gatti, Maurizio Rossini, Alessandro Giollo, (unknown), Francesco Bertoldo, Eugenia Bertoldo, Amy S. Mudano, Kenneth G. Saag, Ombretta Viapiana, Angelo Fassio
8
5
The Living Donor Navigator Program Provides Support Tools for Caregivers
2020 ·Progress in Transplantation ·Rhiannon D. Reed, (unknown), (unknown), (unknown), (unknown), Vineeta Kumar, J. Nicholas Dionne‐Odom, Kenneth G. Saag, Lisle Hites, (unknown), Jayme E. Locke
2
6
Morphea-like skin lesions reported in the phase 3 Long-Term Odanacatib Fracture Trial (LOFT) in postmenopausal women with osteoporosis
2020 ·Journal of the American Academy of Dermatology ·Kenneth G. Saag, T. J. de Villiers, Peter Alexandersen, Heidi Jacobe, Carrie Kovarik, Victoria P. Werth, Albert Leung, (unknown), (unknown), Deborah M. Gurner
2
7
Real-world bone turnover marker use: impact on treatment decisions and fracture
2020 ·Osteoporosis International ·Nancy E. Lane, Kenneth G. Saag, (unknown), (unknown), Roma Shah, (unknown), Richard Eastell
15
8
American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID‐19 Pandemic: Version 2
2020 ·Arthritis & Rheumatology ·Ted R. Mikuls, Sindhu R. Johnson, Liana Fraenkel, Reuben J. Arasaratnam, Lindsey R. Baden, Bonnie L. Bermas, Winn Chatham, Stanley Cohen, Karen H. Costenbader, Ellen M. Gravallese, André C. Kalil, Michael E. Weinblatt, Kevin Winthrop, Amy S. Mudano, Amy S. Turner, Kenneth G. Saag
42
9
Effect of Denosumab Compared With Risedronate on Bone Strength in Patients Initiating or Continuing Glucocorticoid Treatment
2020 ·Journal of Bone and Mineral Research ·Piet Geusens, (unknown), Bert van Rietbergen, Osvaldo Daniel Messina, Éric Lespessailles, Beatriz Oliveri, Roland Chapurlat, Klaus Engelke, Arkadi Chines, Shuang Huang, Kenneth G. Saag, Joop P. van den Bergh
10
10
American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID‐19 Pandemic: Version 1
2020 ·Arthritis & Rheumatology ·Ted R. Mikuls, Sindhu R. Johnson, Liana Fraenkel, Reuben J. Arasaratnam, Lindsey R. Baden, Bonnie L. Bermas, (unknown), Stanley Cohen, Karen H. Costenbader, Ellen M. Gravallese, André C. Kalil, Michael E. Weinblatt, Kevin Winthrop, Amy S. Mudano, Amy S. Turner, Kenneth G. Saag
97
11
Is there a role for cherries in the management of gout?
2019 ·Therapeutic Advances in Musculoskeletal Disease ·(unknown), Kenneth G. Saag, Jasvinder A. Singh
18
12
Changes in Dkk-1, sclerostin, and RANKL serum levels following discontinuation of long-term denosumab treatment in postmenopausal women
2019 ·Bone ·Angelo Fassio, Giovanni Adami, Camilla Benini, Elisabetta Vantaggiato, Kenneth G. Saag, Alessandro Giollo, (unknown), Ombretta Viapiana, Luca Idolazzi, Giovanni Orsolini, Maurizio Rossini, Davide Gatti
31
13
Design, analysis, power, and sample size calculation for three‐phase interrupted time series analysis in evaluation of health policy interventions
2019 ·Journal of Evaluation in Clinical Practice ·Bo Zhang, Wei Liu, Stephenie C. Lemon, Bruce Barton, Melissa A. Fischer, Colleen Lawrence, Elizabeth J. Rahn, Maria I. Danila, Kenneth G. Saag, Paul A. Harris, Jeroan J. Allison
8
14
ACTIVExtend: 24 Months of Alendronate After 18 Months of Abaloparatide or Placebo for Postmenopausal Osteoporosis
2018 ·The Journal of Clinical Endocrinology & Metabolism ·Henry G. Bone, Felicia Cosman, Paul D. Miller, Gregory C. Williams, Gary Hattersley, Ming‐yi Hu, Lorraine A. Fitzpatrick, Bruce Mitlak, Socrates E. Papapoulos, René Rizzoli, Robin K. Dore, John P. Bilezikian, Kenneth G. Saag
129
15
Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout breakdown →
2018 ·New England Journal of Medicine ·William B. White, Kenneth G. Saag, Michael A. Becker, Jeffrey Borer, Philip B. Gorelick, Andrew Whelton, Barbara Hunt, (unknown), Lhanoo Gunawardhana
578
16
PAIN MANAGEMENT
2016 ·The Gerontologist ·(unknown), Helene H. Fung, Jack Tsai, Phi Duong Nguyễn, (unknown), (unknown), Nicole C. Wright, Douglas W. Roblin, Kenneth G. Saag, Peter Cram, Fredric D. Wolinsky
1
17
Socio-demographic differences in risk information seeking sources for non-steroidal anti-inflammatory drugs (NSAIDS)
2016 ·International Journal of Medical Informatics ·Shannon H. Houser, (unknown), Michael J. Miller, Lang Chen, Ryan C. Outman, Midge N. Ray, Kenneth G. Saag, Robert Weech‐Maldonado
1
18
Bisphosphonates and glucocorticoid osteoporosis in men: results of a randomized controlled trial comparing zoledronic acid with risedronate
2012 ·The HKU Scholars Hub (University of Hong Kong) ·Philip N. Sambrook, (unknown), (unknown), Kenneth G. Saag, (unknown), Jean‐Yves Reginster, (unknown), Guoqin Su, David M. Reid
48
19
Benefit of Adherence With Bisphosphonates Depends on Age and Fracture Type: Results From an Analysis of 101,038 New Bisphosphonate Users
2008 ·Journal of Bone and Mineral Research ·Jeffrey R. Curtis, Andrew O. Westfall, Hong Cheng, Kenneth W. Lyles, Kenneth G. Saag, Elizabeth Delzell
95
20
Blood transfusion, alcohol use, and anthropometric risk factors for rheumatoid arthritis in older women.
2002 ·PubMed ·James R. Cerhan, Kenneth G. Saag, Lindsey A. Criswell, Linda Merlino, Ted R. Mikuls
104

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniel H. Solomon Breakdown of academic impact, for papers by Jeffrey R. Curtis Breakdown of academic impact, for papers by Claus Christiansen Breakdown of academic impact, for papers by Michael Doherty Breakdown of academic impact, for papers by Cynthia S. Crowson Breakdown of academic impact, for papers by Hang Lee Breakdown of academic impact, for papers by Sherine E. Gabriel Breakdown of academic impact, for papers by Matthew H. Liang Breakdown of academic impact, for papers by Hyon K. Choi Breakdown of academic impact, for papers by Tore K Kvien
Rankless by CCL
2026